Allena Pharmaceuticals, Inc. (ALNA)
(Delayed Data from NSDQ)
$6.30 USD
+0.20 (3.28%)
Updated May 3, 2019 04:00 PM ET
After-Market: $6.30 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Allena Pharmaceuticals, Inc. [ALNA]
Reports for Purchase
Showing records 61 - 80 ( 170 total )
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Honing Reloxaliase URIROX-2 and Clin-Reg Path for EH with Advanced CKD
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Yas'' Weekly Recap of Our Key Notes
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Part 3: Expert Call Recap for 2019 in Rare Disease
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Part 3: "Must-See" Companies at JPM (Mkt. Cap. <$100M) With 1Q20 Catalysts
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Yas'' Weekly Recap of Our Key Notes and Upcoming Events
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Must Read - Our Takeaway Note with Dr. Orson Moe
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Join Our EH Expert Call Today at 12pm ET with Dr. Orson Moe
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Why You Can''t Miss Our Four Doc Calls on mRNA, PPAR, Hyperoxaluria, Acromegaly
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Realignment Extends Cash Runway into Q4:20; Selloff Overdone
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Join our Dec. 11 Call to Dive into How URIROX-1 Checks all Boxes for EH
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Our Holiday Gift: Join Our mRNA, NASH, Acromegaly, Enteric Hyperoxaluria Calls
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
KOL Enthusiastic About Reloxaliase and Likely to Prescribe for EH Patients
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Allena Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials; We Project Runway into Q3:20 Covers Pipeline Progress
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L